BioMark Diagnostics's total assets for Q4 2024 were C$3.13M, an increase of 257.54% from the previous quarter. TSE:BUX total liabilities were C$1.39M for the fiscal quarter, a -29.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.